Adenosine relaxes vagina smooth muscle through the cyclic guanosine monophosphate– and cyclic guanosine monophosphate–dependent pathways
The Journal of Sexual Medicine · 2025
DOI: 10.1093/jsxmed/qdae150 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Sexual Medicine, 2025. Verfasst von Ilaria Cellai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Andrology and Gender Endocrinology Unit, Department of Experimental Clinical and Biomedical Sciences "Mario Serio", University of Florence, Florence,…. Hauptthemen laut MEDLINE: Vagina, Rats, Sprague-Dawley, Muscle, Smooth, Cyclic GMP. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Progetti di Rilevante Interesse Nazionale, Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
Background
In males, adenosine (ADO) is known to relax penile smooth muscles, although its role in the vagina is not yet fully elucidated.
Aim
This study investigated the effect of ADO on vagina smooth muscle activity, using a validated female Sprague–Dawley rat model.
Methods
Contractility studies, using noradrenaline-precontracted vaginal strips, tested the effects of ADORA1/3 antagonists and ADORA2A/2B antagonists and agonists. Increasing doses of ADO were tested after in vivo or in vitro treatment with Nω-nitro-L-arginine-methyl-ester hydrochloride (L-NAME) or with guanylate or adenylate cyclase inhibitors. Immunopositivity for ADORA2A and ADORA2B was assessed, and messenger RNA (mRNA) analysis was performed. Cyclic ADO monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were quantified both in rat vagina smooth muscle cells (rvSMCs) and in vaginal tissues with increasing doses of ADO. Outcomes Demonstrating ADO’s role in the relaxing/contractile mechanism in distal vagina smooth muscle.
Results
All ADO receptors mRNAs were expressed in vaginal tissue, with a prevalent content of ADORA2B. A high expression of genes regulating ADO catabolism (ADK) and de novo synthesis (NT5E) was found. In vaginal strips, ADO induced relaxation with IC50 = 144.7 μM and a flat pseudo-Hill coefficient value = -0.42, indicating an activity on heterogeneous receptors. Blocking ADORA1/3 shifted ADO response to the left and with a steeper slope. ADORA2A/2B agonists showed a higher potency than ADO in inducing relaxation. Immunolocalization confirmed the presence of ADORA2A/2B in vaginal musculature, in the blood vessels endothelium, and in the epithelium. ADO stimulation of vagina tissues induced a significant increase in cAMP and cGMP contents. Experiments on rvSMCs confirmed that ADO time- and dose-dependently stimulated cAMP production in these cells. However, ADORA2A/2B antagonists, although reducing the ADO-induced relaxation, did not completely block it. A similar inhibition was obtained by blocking adenylate cyclase. Overall, these findings suggest that ADO relaxation involves other pathways, eg, nitric oxide (NO)/cGMP. Accordingly, blocking NO formation through L-NAME substantially blunted ADO responsiveness, as it does the block of cGMP formation through 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin−1-one. Simultaneous incubation with cGMP and cAMP blockers completely inhibited ADO responsiveness. Clinical Translation The study highlights ADO’s role in regulating vaginal smooth muscle activity, suggesting its potential effect on the vagina. Strengths and Limitations This is the first study on ADO in the vagina, although the results are preliminary and limited to the rat model.
Conclusion
These results show that ADO acts as a vaginal relaxing modulator through selective activation of receptors involving not only cAMP but also cGMP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Andrology and Gender Endocrinology Unit, Department of Experimental Clinical and Biomedical Sciences "Mario Serio", University of Florence, Florence, 50134, Italy.
- Interdepartmental Laboratory of Functional and Cellular Pharmacology of Reproduction, Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, 50139, Italy.
- Section of Human Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, Florence, 50134, Italy.
- Endocrinology Unit, Department of Experimental Clinical and Biomedical Sciences "Mario Serio", University of Florence, Florence, 50134, Italy.
- I.N.B.B. (Istituto Nazionale Biostrutture e Biosistemi), Rome, 00136, Italy.
Förderung
- Progetti di Rilevante Interesse Nazionale
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Cellai, I., Filippi, S., Comeglio, P., Guarnieri, G., Acciai, G., Cancedda, C., Cipriani, S., Maseroli, E., Rastrelli, G., Morelli, A., Maggi, M., & Vignozzi, L. (2025). Adenosine relaxes vagina smooth muscle through the cyclic guanosine monophosphate– and cyclic guanosine monophosphate–dependent pathways. The Journal of Sexual Medicine. https://doi.org/10.1093/jsxmed/qdae150
Vancouver
Cellai I, Filippi S, Comeglio P, Guarnieri G, Acciai G, Cancedda C, et al. Adenosine relaxes vagina smooth muscle through the cyclic guanosine monophosphate– and cyclic guanosine monophosphate–dependent pathways. The Journal of Sexual Medicine. 2025. doi:10.1093/jsxmed/qdae150
BibTeX
@article{Cellai2025,
author = {Cellai, Ilaria and Filippi, Sandra and Comeglio, Paolo and Guarnieri, Giulia and Acciai, Gabriele and Cancedda, Chiara and Cipriani, Sarah and Maseroli, Elisa and Rastrelli, Giulia and Morelli, Annamaria and Maggi, Mario and Vignozzi, Linda},
title = {Adenosine relaxes vagina smooth muscle through the cyclic guanosine monophosphate– and cyclic guanosine monophosphate–dependent pathways},
journal = {The Journal of Sexual Medicine},
year = {2025},
doi = {10.1093/jsxmed/qdae150}
}
EUVIMED